204 related articles for article (PubMed ID: 22672838)
1. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
[TBL] [Abstract][Full Text] [Related]
2. MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis.
Fu S; Guo Y; Chen H; Xu ZM; Qiu GB; Zhong M; Sun KL; Fu WN
PLoS One; 2011; 6(10):e25648. PubMed ID: 21998677
[TBL] [Abstract][Full Text] [Related]
3. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
4. Expression of CBY and methylation of CBY at promoter region in human laryngeal squamous cell carcinoma.
Ren G; Zhao DA; Xu J; Li BA
Tumori; 2015; 101(2):215-22. PubMed ID: 25838250
[TBL] [Abstract][Full Text] [Related]
5. The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma.
Wang J; Chen H; Fu S; Xu ZM; Sun KL; Fu WN
Oral Oncol; 2011 Jul; 47(7):601-8. PubMed ID: 21636313
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
7.
Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
[TBL] [Abstract][Full Text] [Related]
8. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
Qu SY; Sun YY; Li YH; Xu ZM; Fu WN
Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
[TBL] [Abstract][Full Text] [Related]
9. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
[TBL] [Abstract][Full Text] [Related]
10. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.
Meng W; Cui W; Zhao L; Chi W; Cao H; Wang B
J Biomed Sci; 2019 Jan; 26(1):13. PubMed ID: 30684967
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
13. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
14. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
He L; Ji W; Yang J; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
[TBL] [Abstract][Full Text] [Related]
15. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma].
Bai W; Li W; Chen X; Wang T
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):254-6. PubMed ID: 16739377
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
[TBL] [Abstract][Full Text] [Related]
19. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
